Compugen
A clinical-stage cancer immunotherapy company and a pioneer in computational target discovery
112 employees · est. 1993 · Israel
Mabqi
Your key partner for breakthrough antibody discovery
26 employees · est. 2017 · Grabels, France
Compugen is the older company (1993 vs 2017); Compugen is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Compugen | Mabqi |
|---|---|---|
| Founded | ||
| Founded | 1993 older | 2017 |
| Headquarters | ||
| Headquarters | Israel | Grabels, France |
| Employees | ||
| Employees | 112 larger | 26 |
| Industry | ||
| Industry | Analytics, Biotechnology, Computing | Biotechnology |
| Funding Stage | ||
| Funding Stage | IPO | Not tracked yet |
| Total Funding | ||
| Total Funding | $126.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 6 | Not tracked yet |
| Services | ||
| Services | Drug Discovery, Clinical Trials, Therapeutic Development, AI/ML Application in Drug Research | Discovery and development of fully human antibodies, Antibody Drug Discovery, Antibody Maturation, LiteMab Antibody Discovery Studio services |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Investors, Healthcare Providers, Cancer Research Organizations, Oncology Researchers | Pharmaceutical Companies, Biotechnology Firms, Oncology Researchers, Clinical Research Organizations |
| Taxonomy | ||
| Taxonomy | Cancer Immunotherapy, Computational Target Discovery, AI/ML Powered Discovery, Fc-reduced Antibodies, Bispecific Antibody Development, TIGIT Targeting Programs, PD-1/TIGIT Bispecific Antibodies, Immuno-Oncology, In Silico Prediction, Pharmaceutical Partnerships, Machine Learning Systems, Drug Development Pipeline, Therapeutic Discovery, In Silico Hypothesis-Driven Discovery, Experimental Validation | Antibody Discovery, Fully Human Antibody Discovery, Therapeutic Antibodies, Oncology Applications, Antibody Affinity Maturation, Antibody Optimization, PH-Sensitive Antibodies, Monoclonal Antibodies, Multispecific Antibodies, Synthetic Antibody Library, Phage Display, Yeast Display, Antibody Development, Immuno-Oncology, Bispecific Antibodies |
| Website | ||
| Website | cgen.com | mabqi.com |
About Compugen
Compugen is a clinical-stage company specializing in cancer immunotherapy, leveraging its AI/ML-powered computational discovery platform, Unigen™. Founded in 1993, this Israel-based firm is recognized for its pioneering role in computational target discovery. Compugen's innovative pipeline includes...
About Mabqi
Mabqi, founded in 2017 and headquartered in France, is emerging as a pivotal player in the Biotechnology industry with its cutting-edge approaches to antibody discovery. Under its slogan, "Your key partner for breakthrough antibody discovery," the company leverages proprietary technology, employing...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Compugen and Mabqi — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Compugen and Mabqi — by email.
Frequently Asked Questions
Compare Compugen with someone else
Start typing a company name or domain.